These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25744741)
1. Cardiological aspects of stroke prevention. Fisher M; McAllister M Circ J; 2015; 79(2):271-7. PubMed ID: 25744741 [TBL] [Abstract][Full Text] [Related]
2. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials. Renda G; di Nicola M; De Caterina R Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790 [TBL] [Abstract][Full Text] [Related]
3. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran]. Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016 [TBL] [Abstract][Full Text] [Related]
4. Prevention of cardioembolic stroke in patients with atrial fibrillation. Weber R; Diener HC; Weimar C Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927 [TBL] [Abstract][Full Text] [Related]
5. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007). Shroff GR; Solid CA; Herzog CA JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657 [No Abstract] [Full Text] [Related]
6. Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes. Gokcal E; Pasi M; Fisher M; Gurol ME Curr Neurol Neurosci Rep; 2018 Feb; 18(2):6. PubMed ID: 29411147 [TBL] [Abstract][Full Text] [Related]
8. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
9. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke. Sanoski CA J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506 [TBL] [Abstract][Full Text] [Related]
10. [Anticoagulant treatment in patients with atrial fibrillation, according to risk factors for stroke]. Lamy C; Mas JL Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):23-33. PubMed ID: 24463061 [TBL] [Abstract][Full Text] [Related]
11. Novel oral anticoagulants in secondary prevention of stroke. Diener HC; Easton JD; Hankey GJ; Hart RG Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901 [TBL] [Abstract][Full Text] [Related]
12. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. Yu HC; Tsai YF; Chen MC; Yeh CH Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation. Han J; Cheng J; Mathuria N Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616 [TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants in non-valvular atrial fibrillation. Potpara TS; Lip GY Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900 [TBL] [Abstract][Full Text] [Related]
15. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Savelieva I; Bajpai A; Camm AJ Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570 [TBL] [Abstract][Full Text] [Related]